18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor


Acar E., ÇAPA KAYA G.

CLINICAL NUCLEAR MEDICINE, vol.44, no.1, pp.53-54, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 44 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.1097/rlu.0000000000002322
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.53-54
  • Keywords: DOTATATE, FDG, large cell neuroendocrine prostate cancer, PET/CT, PSMA, GA-68-PSMA, DIFFERENTIATION, CARCINOMA, UTILITY, CANCER, PET/CT
  • Dokuz Eylül University Affiliated: Yes

Abstract

Prostate large cell neuroendocrine tumor is a rare disease. In this case, metastatic areas showing FDG uptake, somatostatin receptor positivity, and PSMA expression are shown in F-18-FDG PET/CT, Ga-68-DOTATATE PET/CT, and Ga-68-PSMA PET/CT in a 70-year-old man with the diagnosis of prostate large cell neuroendocrine carcinoma.